Eli Lilly (LLY) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to -$9.9 billion.
- Eli Lilly's Enterprise Value fell 18670.33% to -$9.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.9 billion, marking a year-over-year decrease of 18670.33%. This contributed to the annual value of -$3.3 billion for FY2024, which is 1790.61% down from last year.
- As of Q3 2025, Eli Lilly's Enterprise Value stood at -$9.9 billion, which was down 18670.33% from -$3.5 billion recorded in Q2 2025.
- Eli Lilly's 5-year Enterprise Value high stood at -$2.1 billion for Q4 2022, and its period low was -$9.9 billion during Q3 2025.
- Over the past 5 years, Eli Lilly's median Enterprise Value value was -$3.1 billion (recorded in 2021), while the average stood at -$3.3 billion.
- As far as peak fluctuations go, Eli Lilly's Enterprise Value surged by 4411.47% in 2022, and later tumbled by 18670.33% in 2025.
- Eli Lilly's Enterprise Value (Quarter) stood at -$3.7 billion in 2021, then soared by 44.11% to -$2.1 billion in 2022, then crashed by 35.94% to -$2.8 billion in 2023, then fell by 17.91% to -$3.3 billion in 2024, then crashed by 194.76% to -$9.9 billion in 2025.
- Its Enterprise Value was -$9.9 billion in Q3 2025, compared to -$3.5 billion in Q2 2025 and -$3.1 billion in Q1 2025.